
Jeffrey S. Parkin
Examiner (ID: 2776)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1648, 1641, 1813, 1671 |
| Total Applications | 1731 |
| Issued Applications | 935 |
| Pending Applications | 260 |
| Abandoned Applications | 571 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5661479
[patent_doc_number] => 20060252075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Method for monitoring anti-HIV treatment in HIV infected individuals'
[patent_app_type] => utility
[patent_app_number] => 11/404115
[patent_app_country] => US
[patent_app_date] => 2006-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20340
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252075.pdf
[firstpage_image] =>[orig_patent_app_number] => 11404115
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/404115 | Method for monitoring anti-HIV treatment in HIV infected individuals | Apr 13, 2006 | Abandoned |
Array
(
[id] => 4553572
[patent_doc_number] => 07838001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-23
[patent_title] => 'Synthetic peptides useful in biological essays for detecting infections caused by group O HIV-1 viruses'
[patent_app_type] => utility
[patent_app_number] => 11/402876
[patent_app_country] => US
[patent_app_date] => 2006-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7952
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 308
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/838/07838001.pdf
[firstpage_image] =>[orig_patent_app_number] => 11402876
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/402876 | Synthetic peptides useful in biological essays for detecting infections caused by group O HIV-1 viruses | Apr 12, 2006 | Issued |
Array
(
[id] => 6252354
[patent_doc_number] => 20100028415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'Method of Inducing Neutralizing Antibodies to Human Immunodeficiency Virus'
[patent_app_type] => utility
[patent_app_number] => 11/918219
[patent_app_country] => US
[patent_app_date] => 2006-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 7654
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028415.pdf
[firstpage_image] =>[orig_patent_app_number] => 11918219
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/918219 | Method of Inducing Neutralizing Antibodies to Human Immunodeficiency Virus | Apr 11, 2006 | Abandoned |
Array
(
[id] => 5661084
[patent_doc_number] => 20060251680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Mannose immunogens for HIV-1'
[patent_app_type] => utility
[patent_app_number] => 11/376549
[patent_app_country] => US
[patent_app_date] => 2006-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6084
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20060251680.pdf
[firstpage_image] =>[orig_patent_app_number] => 11376549
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/376549 | Mannose immunogens for HIV-1 | Mar 15, 2006 | Abandoned |
Array
(
[id] => 7488821
[patent_doc_number] => 08029797
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-04
[patent_title] => 'Multivalent HIV immunogenic compositions comprising a pool of lipidated and nonlipidated peptides representing Gag and Env variable regions'
[patent_app_type] => utility
[patent_app_number] => 11/817640
[patent_app_country] => US
[patent_app_date] => 2006-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 58
[patent_no_of_words] => 9863
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/029/08029797.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817640
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817640 | Multivalent HIV immunogenic compositions comprising a pool of lipidated and nonlipidated peptides representing Gag and Env variable regions | Feb 27, 2006 | Issued |
Array
(
[id] => 5785448
[patent_doc_number] => 20060205070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'HIV TEV compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/364873
[patent_app_country] => US
[patent_app_date] => 2006-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 27058
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205070.pdf
[firstpage_image] =>[orig_patent_app_number] => 11364873
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/364873 | HIV TEV compositions and methods of use | Feb 26, 2006 | Abandoned |
Array
(
[id] => 5619428
[patent_doc_number] => 20060188961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of modified vaccinia virus ankara'
[patent_app_type] => utility
[patent_app_number] => 11/355948
[patent_app_country] => US
[patent_app_date] => 2006-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 19129
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188961.pdf
[firstpage_image] =>[orig_patent_app_number] => 11355948
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/355948 | Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara | Feb 16, 2006 | Issued |
Array
(
[id] => 5514721
[patent_doc_number] => 20090215028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Methods and Compositions for Determining Anti-HIV Drug Susceptibility and Replication Capacity of HIV'
[patent_app_type] => utility
[patent_app_number] => 11/884668
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20964
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215028.pdf
[firstpage_image] =>[orig_patent_app_number] => 11884668
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/884668 | Methods and Compositions for Determining Anti-HIV Drug Susceptibility and Replication Capacity of HIV | Feb 15, 2006 | Abandoned |
Array
(
[id] => 9749597
[patent_doc_number] => 08841068
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-23
[patent_title] => 'Human immunodeficiency virus antiviral screening assay involving the detection of CEM15 expression'
[patent_app_type] => utility
[patent_app_number] => 11/816063
[patent_app_country] => US
[patent_app_date] => 2006-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 28040
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11816063
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/816063 | Human immunodeficiency virus antiviral screening assay involving the detection of CEM15 expression | Feb 12, 2006 | Issued |
Array
(
[id] => 4785483
[patent_doc_number] => 20080138812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Screening Method For Competitive Hiv Rt Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/814841
[patent_app_country] => US
[patent_app_date] => 2006-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6957
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20080138812.pdf
[firstpage_image] =>[orig_patent_app_number] => 11814841
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/814841 | Screening Method For Competitive Hiv Rt Inhibitors | Feb 5, 2006 | Abandoned |
Array
(
[id] => 4852037
[patent_doc_number] => 20080317779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Hiv Tat-Cd4 Hybrid Molecules and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/883696
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 24606
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20080317779.pdf
[firstpage_image] =>[orig_patent_app_number] => 11883696
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/883696 | Fusion proteins comprising CD4 minimal modules and human immunodeficiency virus (HIV) Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes | Feb 2, 2006 | Issued |
Array
(
[id] => 5667595
[patent_doc_number] => 20060172945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Human neutrophil alpha-defensin 4 inhibition of HIV-1'
[patent_app_type] => utility
[patent_app_number] => 11/347538
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2991
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20060172945.pdf
[firstpage_image] =>[orig_patent_app_number] => 11347538
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/347538 | Human neutrophil alpha-defensin 4 inhibition of HIV-1 | Feb 2, 2006 | Abandoned |
Array
(
[id] => 5700015
[patent_doc_number] => 20060216699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Peptides for the detection of HIV-1 group O'
[patent_app_type] => utility
[patent_app_number] => 11/341363
[patent_app_country] => US
[patent_app_date] => 2006-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6975
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20060216699.pdf
[firstpage_image] =>[orig_patent_app_number] => 11341363
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/341363 | Peptides for the detection of HIV-1 group O | Jan 25, 2006 | Abandoned |
Array
(
[id] => 9073907
[patent_doc_number] => 08551483
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-08
[patent_title] => 'Methods of treating viral infections by administering KIR2DL-binding antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/813399
[patent_app_country] => US
[patent_app_date] => 2006-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15588
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11813399
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/813399 | Methods of treating viral infections by administering KIR2DL-binding antibodies | Jan 5, 2006 | Issued |
Array
(
[id] => 836816
[patent_doc_number] => 07393631
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-01
[patent_title] => 'Method for purifying adenoviruses'
[patent_app_type] => utility
[patent_app_number] => 11/326275
[patent_app_country] => US
[patent_app_date] => 2006-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3412
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/393/07393631.pdf
[firstpage_image] =>[orig_patent_app_number] => 11326275
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/326275 | Method for purifying adenoviruses | Jan 4, 2006 | Issued |
Array
(
[id] => 4681837
[patent_doc_number] => 20080248063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Hetero-Oligomeric Hiv Envelope Proteins'
[patent_app_type] => utility
[patent_app_number] => 11/722336
[patent_app_country] => US
[patent_app_date] => 2005-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8284
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20080248063.pdf
[firstpage_image] =>[orig_patent_app_number] => 11722336
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/722336 | Hetero-Oligomeric Hiv Envelope Proteins | Dec 27, 2005 | Abandoned |
Array
(
[id] => 852883
[patent_doc_number] => 07378265
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-27
[patent_title] => 'Method of inactivating enveloped viruses in a viral preparation of non-enveloped viruses'
[patent_app_type] => utility
[patent_app_number] => 11/301160
[patent_app_country] => US
[patent_app_date] => 2005-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12935
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/378/07378265.pdf
[firstpage_image] =>[orig_patent_app_number] => 11301160
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/301160 | Method of inactivating enveloped viruses in a viral preparation of non-enveloped viruses | Dec 11, 2005 | Issued |
Array
(
[id] => 5613528
[patent_doc_number] => 20060115456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Replication-competent adenoviral vectors'
[patent_app_type] => utility
[patent_app_number] => 11/282319
[patent_app_country] => US
[patent_app_date] => 2005-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16599
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20060115456.pdf
[firstpage_image] =>[orig_patent_app_number] => 11282319
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/282319 | Replication-competent adenoviral vectors | Nov 16, 2005 | Issued |
Array
(
[id] => 4651028
[patent_doc_number] => 20080038284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Human Immunodeficiency Virus Vaccine'
[patent_app_type] => utility
[patent_app_number] => 11/666732
[patent_app_country] => US
[patent_app_date] => 2005-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8217
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20080038284.pdf
[firstpage_image] =>[orig_patent_app_number] => 11666732
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/666732 | Human Immunodeficiency Virus Vaccine | Nov 6, 2005 | Abandoned |
Array
(
[id] => 7811136
[patent_doc_number] => 08133666
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-13
[patent_title] => 'Method for identifying agents capable of inhibiting APOBEC3C activity in HIV-infected cells'
[patent_app_type] => utility
[patent_app_number] => 11/577077
[patent_app_country] => US
[patent_app_date] => 2005-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 19578
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/133/08133666.pdf
[firstpage_image] =>[orig_patent_app_number] => 11577077
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/577077 | Method for identifying agents capable of inhibiting APOBEC3C activity in HIV-infected cells | Oct 30, 2005 | Issued |